Navigation Links
Estrogen helps drive distinct, aggressive form of prostate cancer
Date:5/27/2008

NEW YORK (May 27, 2008) -- Using a breakthrough technology, researchers led by a Weill Cornell Medical College scientist have pinpointed the hormone estrogen as a key player in about half of all prostate cancers.

Estrogen-linked signaling helps drive a discrete and aggressive form of the disease caused by a chromosomal translocation, which in turn results in the fusion of two genes.

"Fifty percent of prostate cancers harbor a common recurrent gene fusion, and we believe that this confers a more aggressive nature to these tumors," explains study senior author Dr. Mark A. Rubin, professor of pathology and laboratory medicine, and vice chair for experimental pathology at Weill Cornell Medical College. Dr. Rubin is also attending pathologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

"Interfering with this gene fusion -- or its downstream molecular pathways -- will be crucial in the search for drugs that fight the disease. Based on our new data, we now believe that inhibiting estrogen may be one way of doing so," he says.

The findings are published in the May 27 online edition of the Journal of the National Cancer Institute. Dr. Rubin conducted the study while at the Brigham and Women's Hospital and in collaboration with Dr. Todd Golub and other members of the Broad Institute of MIT and Harvard, in Cambridge, Mass. His team is now continuing this line of research at Weill Cornell.

Dr. Rubin, along with researchers at the University of Michigan, first discovered and described the common fusions between the TMPRSS2 and ETS family member genes subset of prostate cancer in the journal Science in 2005. "The discovery showed that these malignancies occur after an androgen (male hormone)-dependent gene fuses with an oncogene -- a type of gene that causes cancer," he explains.

Experts have long understood that male hormones help spur prostate cancer -- in fact, androgen-deprivation therapy is a fir
'/>"/>

Contact: Andrew Klein
ank2017@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. High levels of estrogen associated with breast cancer recurrence
2. Dosage of fertilizer helps to enhance quality of wheat
3. Glypican-3 gene function in regulating body size helps inform novel cancer treatments
4. Bacterial slime helps cause serious disease
5. Deadly dose: Rensselaer heparin expert helps uncover source of lethal contamination
6. Underwater microscope helps prevent shellfish poisoning along Gulf Coast of Texas
7. Green tea helps beat superbugs
8. CSHL scientists identify a mechanism that helps fruit flies lock-in memories
9. Dung happens and helps scientists
10. The Uukuniemi virus helps to explain the infection mechanism of bunyaviruses
11. IAEA helps recover stray radioactive sources in Nigeria

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...us,s exquisite specialisation for its human host ...he humble lab mouse, can deliver only limited info...Med Central,s open access Journal of Biology hav...ating a mouse that has key features of HIV infecti...siotis, from the Division of Immunoregulation at M...
(Date:11/30/2009)...0 Neurotechnology ( http://www.neu...iometric identification technologies, has released...ne: VeriLook 4.0 Software Development Kit (SDK) ...or large-scale multi-biometric and automated finge...abilities in VeriLook 4.0 provide enhanced facial ...
(Date:11/26/2009)...er have been caught in the hunters, sights for gen...decorative. They are lethal weapons that stags cra...niversity of York, UK, has been intrigued by the m...ry and has become fascinated by the mechanical pro...ation with Tomas Landete-Castillejos at the Univer...
Breaking Biology News(10 mins):A reductionist approach to HIV research 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 3Tough yet stiff deer antler is materials scientist's dream 2Rodent size linked to human population and climate change 9434 1Rodent size linked to human population and climate change 9434 2Free Compirion Webinar Promotes Nurse Rounding to Improve Patient Safety 53306 1Free Compirion Webinar Promotes Nurse Rounding to Improve Patient Safety 53306 2Free Compirion Webinar Promotes Nurse Rounding to Improve Patient Safety 53306 3British Woman Celebrates a Year of Living Cancer Free 4803 1British Woman Celebrates a Year of Living Cancer Free 4803 2British Woman Celebrates a Year of Living Cancer Free 4803 3British Woman Celebrates a Year of Living Cancer Free 4803 4
...ous in the early 1980s when they stumbled on small...not only were they not supposed to be there, but t...taching to and detaching from proteins, effectivel...dom was that the job of turning proteins on and of... phosphates, in a common and easy-to-detect chemi...
...t Wake Forest University School of Medicine may be...ntraceptive use dramatically lowers the risk of ov... studying the effect of post-menopausal dietary so... monkeys, Latanya M. Scott, Ph.D., discovered that...in life had a reduced amount of estrogen excreted ...
...oratories engineer, and Bruce Osborn, chief operat... honored with a Popular Mechanics magazine Breakth... the Hearst Tower in New York City. , Sponsored b...lebrate innovations poised to change the world and...ES award is among 21 given by the magazine at the ...
Other Biology News:Johns Hopkins researchers detect sweet cacophony while listening to cellular cross-talk 2Birth control has long-term effect on hormone exposure 2Sandia, SES win Popular Mechanics Breakthrough Innovator Award 2
(Date:11/30/2009)... Minn., Nov. 30 Acuo Technologies,...gement software, data migration tools and services...s and Clinics for a new Vendor Neutral Archive (VN...ss the Allina network of hospitals, clinics and af... the Acuo Technologies DICOM Services Grid(TM) Sof...
(Date:11/30/2009)... 30 Dr. Jessica Torrente, Assistan...ersity Medical Center in Washington, D.C., demonst...amma Imaging (BSGI) in clinical practice as an adj...cancer today at the annual meeting of the Radiolog...urpose of the exhibit was to demonstrate how BSGI ...
(Date:11/30/2009)...E, Nov. 30 Cell Therapeu...today that its new class of platinum-based anti-tu... a stronger anti-tumor potency and activity compar... as well as the ability to overcome cisplatin-resi...sented in a paper titled "Novel Bis-platinum Compl...
(Date:11/29/2009)...able in German . , The concept of confineme...The most famous example is that of quarks which bi.... Bella Lake from Helmholtz-Zentrum Berlin togethe...for the first time an experimental realization and...ondensed matter system. , The concept of confine...
Breaking Biology Technology:Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 3Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3Spinons -- confined like quarks 2
..., SEATTLE, May 8 Dendreon Corporation (Nasdaq: ...ten public offering of 10,700,000 shares of its co...sole manager for the offering. Dendreon has grant...e an additional 1,279,166 shares of common stock t...ntends to use the net proceeds of the offering to ...
..., Conference Call Scheduled Today at 4:30pm ET ,...Expected in 1H 2009 , , Company to Provide Up...ll Today , , Corporate Highlights: , , - ... of Qutenza(TM) (formerly NGX-4010) for treatment ...lts, either alone or in combination with other med...
..., -- Management to host call and webcast today at ... recent business highlights -- , , SAN DIEGO, M...EX ), a biopharmaceutical company focused on the t...ancial results for the three months ended March 31..., As of March 31, 2009, Orexigen held $19.8 millio...
Other Biology Technology:Dendreon Announces Common Stock Offering 2NeurogesX Reports First Quarter 2009 Results 2NeurogesX Reports First Quarter 2009 Results 3NeurogesX Reports First Quarter 2009 Results 4NeurogesX Reports First Quarter 2009 Results 5NeurogesX Reports First Quarter 2009 Results 6NeurogesX Reports First Quarter 2009 Results 7NeurogesX Reports First Quarter 2009 Results 8NeurogesX Reports First Quarter 2009 Results 9NeurogesX Reports First Quarter 2009 Results 10NeurogesX Reports First Quarter 2009 Results 11Orexigen(R) Therapeutics Announces First Quarter 2009 Financial Results 2Orexigen(R) Therapeutics Announces First Quarter 2009 Financial Results 3Orexigen(R) Therapeutics Announces First Quarter 2009 Financial Results 4Orexigen(R) Therapeutics Announces First Quarter 2009 Financial Results 5Orexigen(R) Therapeutics Announces First Quarter 2009 Financial Results 6Orexigen(R) Therapeutics Announces First Quarter 2009 Financial Results 7Orexigen(R) Therapeutics Announces First Quarter 2009 Financial Results 8Orexigen(R) Therapeutics Announces First Quarter 2009 Financial Results 9
Epi-Grids Colony Grid Templates-48 Squares from EPICENTRE Biotechnologies
Toxoplasma IgA ELISA Kit, Single from Bio-Quant Inc.
EBV-VCA IgM ELISA Kit, Single from Bio-Quant Inc.
Chlamydia trachomatis IgG ELISA Kit, Single from Bio-Quant Inc.
Biology Products: